Clinical Trials

Sponsor: Genelux Corporation

Sponsor Study ID: 01182022GNLX

Study Title: GOG-3076 a Phase 3 Trial in Platinum-Resistant/Refractory Ovarian Cancer

NCT Number:

Phase: III

Protocol Type: Treatment

Age Group: Adults

Disease Sites: Ovary

Study Objectives:

---

Study Documents    
(MUSC NetID required for document access)